Obestatin promotes cell survival and decreases serum starvation-induced apoptosis at stage 5. by lessandra Baragli (417177)

Inducible and conditional knockout (icKO) of ERK5 decreases adult OB neurogenesis. by Tan Li (404990)

Tethered HP1 Decreases Histone Acetylation throughout the ψVλ Array by W. Jason Cummings (9607)

FABP5 overexpression decreases inflammation and increases innate immunity in primary NHBE cells. by Fabienne Gally (260470)

“…<p><b>A.</b> CS exposure decreases <i>P. aeruginosa</i> colony forming units (CFU) on primary NHBE cells overexpressing FABP5. …”

PFKFB3-4+5 knockdown leads to decreased cell growth and colony formation. by Ulli Heydasch (11091062)

Knockdown of endogenous Cdk-5 decreases T-type Ca2+ channel functional expression. by Aida Calderón-Rivera (701054)

Troglitazone decreases α5 integrin-dependent cell adhesion in K562 cells. by Amanda M. Hanson (543116)

Circulating CXCR5+CD4+ Tfh cells are significantly decreased in HCC patients. by Yiqiong Jia (692871)

Overexpression of PR decreases Myc expression and activity. by Tamar Kavlashvili (849072)

Cardamonin decreased the expression of lipogenic proteins. by Peiguang Niu (17044532)

Unusual [3+1] Cycloaddition of a Stable Silylene with a 2,3-Diazabuta-1,3-diene versus [4+1] Cycloaddition toward a Buta-1,3-diene by Yun Xiong (1403545)

Subjects:

Distribution of pulmonary ventilation assessed by center of ventilation (CoV) presented over the five time points: Induction-SB, MV-5min, MV-30min, MV-late and recovery-SB. by Milena S. Nascimento (14803681)

VAMP2 decreases 5-HT uptake and SERT cell surface expression in HEK-293 MSR cells by reducing the delivery rate of the transporter to the plasma membrane. by Heidi Kaastrup Müller (570207)

Clinical characteristics. by Jesse A. Davidson (3158913)

Subjects:

13C5-adenosine production with ex vivo alkaline phosphatase supplementation. by Jesse A. Davidson (3158913)

Subjects:

Correlation of AP activity to 13C5-adenosine production pre-operation and prior to separation from cardiopulmonary bypass. by Jesse A. Davidson (3158913)

Subjects:

Pre-operation to rewarming change in alkaline phosphatase activity versus change in 13C5-adenosine with CD73 inhibition. by Jesse A. Davidson (3158913)

Subjects:

Pre-operation to rewarming change in alkaline phosphatase activity versus change in 13C5-adenosine without CD73 inhibition. by Jesse A. Davidson (3158913)

Subjects:

13C5-adenosine production without ectonucleotidase inhibition, with CD73 inhibition, and with alkaline phosphatase inhibition. by Jesse A. Davidson (3158913)

Subjects:

Adenosine production with AP supplementation + = significant at the 0.05 level adjusted for multiple comparisons. by Jesse A. Davidson (3158913)

Subjects: